CompletedNot Applicable

The Efficacy of N-acetyl-cysteine in the Treatment of Burning Mouth Syndrome

Croatia80 participantsStarted 2022-05-01

Plain-language summary

The purpose of this study was to examine the efficacy of N-acetyl cysteine in the treatment of burning mouth syndrome. A control group of patients with burning mouth syndrome will receive a placebo. The effect of the therapy will be monitored with the help of the visual-analogue scale (VAS) and the oral health-related quality of life questionnaire (OHIP-14).

Who can participate

Age range18 Years – 70 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * clinical diagnosis of burning mouth syndrome Exclusion Criteria: * pregnancy, breastfeeding or pregnancy planning * anamnestic data about active gastric or duodenal ulcer * decreased levels of serum iron or B vitamins

What they're measuring

Change in quality of life

Timeframe: up to 8 weeks

Trial details

NCT IDNCT05309070

SponsorUniversity of Zagreb

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-02-28

View on ClinicalTrials.gov More Burning Mouth Syndrome trials